02.13.14
Cook Medical has released a new endobronchial ultrasound (EBUS) needle, a single-use, disposable item for fine-needle biopsy (FNB) intended for sampling of submucosal and extramural lesions within or adjacent to the tracheobronchial tree or gastrointestinal tract.
It reportedly is the first endobronchial ultrasound (EBUS) needle to be introduced in the United States that can acquire histological samples. The EBUS needle offers an option that promises easier and cleaner results than standard fine needle aspiration, according to Cook.
The EchoTip ProCore EBUS needle is designed with a core-trap technology that gives physicians the ability to retrieve both cell and tissue samples from lymph nodes or tumours in the pulmonary area.
Until now, histological samples commonly have been acquired by other more invasive modalities to diagnose malignant and benign lesions of the GI tract. Now, with Cook's EchoTip ProCore, tissue samples can be obtained using the less-invasive procedure.
Cook Medical Endoscopy division global leader Barry Slowey sai,: "We are pleased that physicians can now use the same technology in the pulmonary area, and we hope that this technology will aid in quick and accurate diagnosis for patients."
The company recently introduced the 25-gage EchoTip Ultra endobronchial ultrasound needle, which has been designed to be 33 percent more flexible than the 22-gage needle. This flexibility allows physicians to deflect the endoscope to a greater degree than is possible with larger needles.
Cook executives said the added flexibility also can allow physicians to reach more pulmonary target lesions.
GlobalData estimated the U.S. fine aspiration needles market to be $12.4 million in 2012; the market analysis and consulting firm expects the sector to grow at a compound annual growth rate of 3.2 percent to reach $15.4 million by 2019.
It reportedly is the first endobronchial ultrasound (EBUS) needle to be introduced in the United States that can acquire histological samples. The EBUS needle offers an option that promises easier and cleaner results than standard fine needle aspiration, according to Cook.
The EchoTip ProCore EBUS needle is designed with a core-trap technology that gives physicians the ability to retrieve both cell and tissue samples from lymph nodes or tumours in the pulmonary area.
Until now, histological samples commonly have been acquired by other more invasive modalities to diagnose malignant and benign lesions of the GI tract. Now, with Cook's EchoTip ProCore, tissue samples can be obtained using the less-invasive procedure.
The company recently introduced the 25-gage EchoTip Ultra endobronchial ultrasound needle, which has been designed to be 33 percent more flexible than the 22-gage needle. This flexibility allows physicians to deflect the endoscope to a greater degree than is possible with larger needles.
Cook executives said the added flexibility also can allow physicians to reach more pulmonary target lesions.
GlobalData estimated the U.S. fine aspiration needles market to be $12.4 million in 2012; the market analysis and consulting firm expects the sector to grow at a compound annual growth rate of 3.2 percent to reach $15.4 million by 2019.